Stock Market Reviews

YI (111, Inc.) News

Get the latest news, insights, and market updates on YI (111, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• 111 Full Year 2024 Earnings: CN¥7.54 loss per share (vs CN¥46.58 loss in FY 2023)
  111 ( NASDAQ:YI ) Full Year 2024 Results Key Financial Results Revenue: CN¥14.4b (down 3.7% from FY 2023). Net loss...
  Mar 21, 2025 - $YI
• 111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
  111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.
  Mar 20, 2025 - $YI
• 111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
  111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, March 26, 2025 at 11:00 a.m. ET.
  Mar 12, 2025 - $YI
• 111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow
  111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025.
  Feb 20, 2025 - $YI
• 111, Inc. Regains Compliance with NASDAQ Requirement
  111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") on February 10, 2025, confirming that Nasdaq has determined that for the last ten consecutive business days, from January 24, 2025 to February 7, 2025, the closing bid price of the C
  Feb 11, 2025 - $YI
• US Penny Stocks To Watch In January 2025
  As of January 2025, the U.S. stock market is experiencing a surge, with major indices like the S&P 500 reaching record highs amid strong corporate earnings and optimism about AI-related developments. Penny stocks may be an old term, but they continue to offer intriguing opportunities for investors seeking growth at lower price points. Typically representing smaller or newer companies, these stocks can present significant upside potential when backed by strong financials and solid fundamentals.
  Jan 24, 2025 - $YI
• 111, Inc. Announces ADS Ratio Change
  111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to Class A ordinary shares from one (1) ADS representing two (2) Class A ordinary shares to the new ratio of one (1) ADS representing twenty (20) Class A ordinary shares.
  Jan 8, 2025 - $YI